PharmaCyte Biotech's total assets for Q were $78.88M, a decrease of -1.26% from the previous quarter. PMCB total liabilities were $20.81M for the fiscal quarter, a -43.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.